UK Series B raises in 2018
1Freeline Therapeutics
Focus: Medical
Founded: 2015
Number of Funding Rounds: 3
Last Funding Date: 20/06/2018
Last Funding Amount: $116,000,000
Total Funding: $156,000,000
Website: freeline.life
Freeline Therapeutics is a biopharmaceutical company specialising in developing liver-directed gene therapies for bleeding disorders.